Among those specifically modulated in GBM, only 3 CPs were predicted to be inhibited by DHA (i.e., IL-10 Signaling, Antioxidant Action of Vitamin C, PPAR Signaling) whereas 136 were activated. The gene discussed is PPARA; the disease is glioblastoma.